Skip to main content

IL-23/TH17 Pathway in Psoriasis and Inflammatory Skin Diseases

  • Chapter
  • First Online:

Abstract

Psoriasis is a highly prevalent and heritable skin disease that affects the population worldwide. While the importance of activated T cells in disease pathogenesis has long been appreciated, the central role of the IL-23/TH17 pathway has only recently been realized. In this chapter, we discuss the contributions of TH17 cells in psoriasis, as well as in other inflammatory skin diseases.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Abrams, J. R., S. L. Kelley, E. Hayes, T. Kikuchi, M. J. Brown, S. Kang, M. G. Lebwohl, C. A. Guzzo, B. V. Jegasothy, P. S. Linsley, and J. G. Krueger. 2000. Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells. J Exp Med 192 (5):681–94.

    Article  PubMed  CAS  Google Scholar 

  • Albanesi, C., A. Cavani, and G. Girolomoni. 1999. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. J Immunol 162 (1):494–502.

    PubMed  CAS  Google Scholar 

  • Arican, O., M. Aral, S. Sasmaz, and P. Ciragil. 2005. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm 2005 (5):273–9.

    Article  PubMed  Google Scholar 

  • Austin, L. M., M. Ozawa, T. Kikuchi, I. B. Walters, and J. G. Krueger. 1999. The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 113 (5):752–9.

    Article  PubMed  CAS  Google Scholar 

  • Bettelli, E., T. Korn, and V. K. Kuchroo. 2007. Th17: the third member of the effector T cell trilogy. Curr Opin Immunol 19 (6):652–7.

    Article  PubMed  CAS  Google Scholar 

  • Boniface, K., E. Guignouard, N. Pedretti, M. Garcia, A. Delwail, F. X. Bernard, F. Nau, G. Guillet, G. Dagregorio, H. Yssel, J. C. Lecron, and F. Morel. 2007. A role for T cell-derived interleukin 22 in psoriatic skin inflammation. Clin Exp Immunol 150 (3):407–15.

    Article  PubMed  CAS  Google Scholar 

  • Brandrup, F., N. Holm, N. Grunnet, K. Henningsen, and H. E. Hansen. 1982. Psoriasis in monozygotic twins: variations in expression in individuals with identical genetic constitution. Acta Derm Venereol 62 (3):229–36.

    PubMed  CAS  Google Scholar 

  • Cargill, M., S. J. Schrodi, M. Chang, V. E. Garcia, R. Brandon, K. P. Callis, N. Matsunami, K. G. Ardlie, D. Civello, J. J. Catanese, D. U. Leong, J. M. Panko, L. B. McAllister, C. B. Hansen, J. Papenfuss, S. M. Prescott, T. J. White, M. F. Leppert, G. G. Krueger, and A. B. Begovich. 2007. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 80 (2):273–90.

    Article  PubMed  CAS  Google Scholar 

  • Caruso, R., E. Botti, M. Sarra, M. Esposito, C. Stolfi, L. Diluvio, M. L. Giustizieri, V. Pacciani, A. Mazzotta, E. Campione, T. T. Macdonald, S. Chimenti, F. Pallone, A. Costanzo, and G. Monteleone. 2009. Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nat Med 15 (9):1013–5.

    Article  PubMed  CAS  Google Scholar 

  • Chang, S. H., and C. Dong. 2007. A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses. Cell Res 17 (5):435–40.

    PubMed  Google Scholar 

  • Christophers, E. 2001. Psoriasis--epidemiology and clinical spectrum. Clin Exp Dermatol 26 (4):314–20.

    Article  PubMed  CAS  Google Scholar 

  • Ciric, B., M. El-behi, R. Cabrera, G. X. Zhang, and A. Rostami. 2009. IL-23 drives pathogenic IL-17-producing CD8+ T cells. J Immunol 182 (9):5296–305.

    Article  PubMed  CAS  Google Scholar 

  • Corrigall, V. M., M. Arastu, S. Khan, C. Shah, M. Fife, T. Smeets, P. P. Tak, and G. S. Panayi. 2001. Functional IL-2 receptor beta (CD122) and gamma (CD132) chains are expressed by fibroblast-like synoviocytes: activation by IL-2 stimulates monocyte chemoattractant protein-1 production. J Immunol 166 (6):4141–7.

    PubMed  CAS  Google Scholar 

  • Csiszar, A., Z. Ungvari, A. Koller, J. G. Edwards, and G. Kaley. 2003. Aging-induced proinflammatory shift in cytokine expression profile in coronary arteries. FASEB J 17 (9):1183–5.

    PubMed  CAS  Google Scholar 

  • de Jongh, G. J., P. L. Zeeuwen, M. Kucharekova, R. Pfundt, P. G. van der Valk, W. Blokx, A. Dogan, P. S. Hiemstra, P. C. van de Kerkhof, and J. Schalkwijk. 2005. High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J Invest Dermatol 125 (6):1163–73.

    Article  Google Scholar 

  • Di Cesare, A., P. Di Meglio, and F. O. Nestle. 2009. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129 (6):1339–50.

    Article  PubMed  Google Scholar 

  • Duerr, R. H., K. D. Taylor, S. R. Brant, J. D. Rioux, M. S. Silverberg, M. J. Daly, A. H. Steinhart, C. Abraham, M. Regueiro, A. Griffiths, T. Dassopoulos, A. Bitton, H. Yang, S. Targan, L. W. Datta, E. O. Kistner, L. P. Schumm, A. T. Lee, P. K. Gregersen, M. M. Barmada, J. I. Rotter, D. L. Nicolae, and J. H. Cho. 2006. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314 (5804):1461–3.

    Article  PubMed  CAS  Google Scholar 

  • Duhen, T., R. Geiger, D. Jarrossay, A. Lanzavecchia, and F. Sallusto. 2009. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 10 (8):857–63.

    Article  PubMed  CAS  Google Scholar 

  • Elder, J. T., A. T. Bruce, J. E. Gudjonsson, A. Johnston, P. E. Stuart, T. Tejasvi, J. J. Voorhees, G. R. Abecasis, and R. P. Nair. 2010. Molecular Dissection of Psoriasis: Integrating Genetics and Biology. J Invest Dermatol 130 (5):1213–26.

    Google Scholar 

  • Ellis, C. N., D. C. Gorsulowsky, T. A. Hamilton, J. K. Billings, M. D. Brown, J. T. Headington, K. D. Cooper, O. Baadsgaard, E. A. Duell, T. M. Annesley, and et al. 1986. Cyclosporine improves psoriasis in a double-blind study. JAMA 256 (22):3110–6.

    Article  PubMed  CAS  Google Scholar 

  • Farber, E. M., M. L. Nall, and W. Watson. 1974. Natural history of psoriasis in 61 twin pairs. Arch Dermatol 109 (2):207–11.

    Article  PubMed  CAS  Google Scholar 

  • Farber, E.M., and M.L. Nall. 1998. Epidemiology: natural history and genetics. In Psoriasis, edited by H. H. Roenigk and H. I. Maibach. New York: Marcel Dekker.

    Google Scholar 

  • Ferenczi, K., L. Burack, M. Pope, J. G. Krueger, and L. M. Austin. 2000. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry. J Autoimmun 14 (1):63–78.

    Article  PubMed  CAS  Google Scholar 

  • Fossiez, F., O. Djossou, P. Chomarat, L. Flores-Romo, S. Ait-Yahia, C. Maat, J. J. Pin, P. Garrone, E. Garcia, S. Saeland, D. Blanchard, C. Gaillard, B. Das Mahapatra, E. Rouvier, P. Golstein, J. Banchereau, and S. Lebecque. 1996. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183 (6):2593–603.

    Article  PubMed  CAS  Google Scholar 

  • Fuhlbrigge, R. C., J. D. Kieffer, D. Armerding, and T. S. Kupper. 1997. Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 389 (6654):978–81.

    Article  PubMed  CAS  Google Scholar 

  • Fujita, H., K.E. Nograles, T. Kikuchi, J. Gonzalez, J.A. Carucci, and J.G. Krueger. 2009. Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production. Proc Natl Acad Sci USA 106 (51):21795–800.

    Article  PubMed  CAS  Google Scholar 

  • Gaffen, S. L. 2009. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 9 (8):556–67.

    Article  PubMed  CAS  Google Scholar 

  • Ganguly, D., G. Chamilos, R. Lande, J. Gregorio, S. Meller, V. Facchinetti, B. Homey, F. J. Barrat, T. Zal, and M. Gilliet. 2009. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med 206 (9):1983–94.

    Article  PubMed  CAS  Google Scholar 

  • Gelfand, J. M., A. B. Troxel, J. D. Lewis, S. K. Kurd, D. B. Shin, X. Wang, D. J. Margolis, and B. L. Strom. 2007. The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol 143 (12):1493–9.

    Article  PubMed  Google Scholar 

  • Gelfand, J. M., R. Weinstein, S. B. Porter, A. L. Neimann, J. A. Berlin, and D. J. Margolis. 2005. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 141 (12):1537–41.

    Article  PubMed  Google Scholar 

  • Gottlieb, A. B., F. Chamian, S. Masud, I. Cardinale, M. V. Abello, M. A. Lowes, F. Chen, M. Magliocco, and J. G. Krueger. 2005. TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques. J Immunol 175 (4):2721–9.

    PubMed  CAS  Google Scholar 

  • Gottlieb, S. L., P. Gilleaudeau, R. Johnson, L. Estes, T. G. Woodworth, A. B. Gottlieb, and J. G. Krueger. 1995. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med 1 (5):442–7.

    Article  PubMed  CAS  Google Scholar 

  • Griffiths, C. E., E. Christophers, J. N. Barker, R. J. Chalmers, S. Chimenti, G. G. Krueger, C. Leonardi, A. Menter, J. P. Ortonne, and L. Fry. 2007. A classification of psoriasis vulgaris according to phenotype. Br J Dermatol 156 (2):258–62.

    Article  PubMed  CAS  Google Scholar 

  • Griffiths, C.E.M., R.D.R. Camp, and J.N.W.N. Barker. 2004. Psoriasis. In Rook’s Textbook of Dermatology, edited by T. Burns, S. Breathnach, N. Cox and C. Griffiths. Oxford: Blackwell Publishing.

    Google Scholar 

  • Guttman-Yassky, E., M. A. Lowes, J. Fuentes-Duculan, L. C. Zaba, I. Cardinale, K. E. Nograles, A. Khatcherian, I. Novitskaya, J. A. Carucci, R. Bergman, and J. G. Krueger. 2008. Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis. J Immunol 181 (10):7420–7.

    PubMed  CAS  Google Scholar 

  • Habib, T., S. Senadheera, K. Weinberg, and K. Kaushansky. 2002. The common gamma chain (gamma c) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3. Biochemistry 41 (27):8725–31.

    Article  PubMed  CAS  Google Scholar 

  • Haider, A. S., M. A. Lowes, M. Suarez-Farinas, L. C. Zaba, I. Cardinale, A. Khatcherian, I. Novitskaya, K. M. Wittkowski, and J. G. Krueger. 2008. Identification of cellular pathways of “type 1,” Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis. J Immunol 180 (3):1913–20.

    PubMed  CAS  Google Scholar 

  • Harper, E. G., C. Guo, H. Rizzo, J. V. Lillis, S. E. Kurtz, I. Skorcheva, D. Purdy, E. Fitch, M. Iordanov, and A. Blauvelt. 2009. Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J Invest Dermatol 129 (9):2175–83.

    Article  PubMed  CAS  Google Scholar 

  • Hashmi, S., and Q. T. Zeng. 2006. Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease. Coron Artery Dis 17 (8):699–706.

    Article  PubMed  Google Scholar 

  • Hedrick, M. N., A. S. Lonsdorf, A. K. Shirakawa, C. C. Richard Lee, F. Liao, S. P. Singh, H. H. Zhang, A. Grinberg, P. E. Love, S. T. Hwang, and J. M. Farber. 2009. CCR6 is required for IL-23-induced psoriasis-like inflammation in mice. J Clin Invest 119 (8):2317–29.

    Article  PubMed  CAS  Google Scholar 

  • Henseler, T., and E. Christophers. 1985. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 13 (3):450–6.

    Article  PubMed  CAS  Google Scholar 

  • Hollox, E. J., U. Huffmeier, P. L. Zeeuwen, R. Palla, J. Lascorz, D. Rodijk-Olthuis, P. C. van de Kerkhof, H. Traupe, G. de Jongh, M. den Heijer, A. Reis, J. A. Armour, and J. Schalkwijk. 2008. Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 40 (1):23–5.

    Article  PubMed  CAS  Google Scholar 

  • Homey, B., M. C. Dieu-Nosjean, A. Wiesenborn, C. Massacrier, J. J. Pin, E. Oldham, D. Catron, M. E. Buchanan, A. Muller, R. deWaal Malefyt, G. Deng, R. Orozco, T. Ruzicka, P. Lehmann, S. Lebecque, C. Caux, and A. Zlotnik. 2000. Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol 164 (12):6621–32.

    PubMed  CAS  Google Scholar 

  • Ishigame, H., S. Kakuta, T. Nagai, M. Kadoki, A. Nambu, Y. Komiyama, N. Fujikado, Y. Tanahashi, A. Akitsu, H. Kotaki, K. Sudo, S. Nakae, C. Sasakawa, and Y. Iwakura. 2009. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30 (1):108–19.

    Article  PubMed  CAS  Google Scholar 

  • Kenney, J.A. 1971. Psoriasis in the American black. In Psoriasis: Proceedings of the International Symposium. Stanford, California: Stanford University Press.

    Google Scholar 

  • Koga, C., K. Kabashima, N. Shiraishi, M. Kobayashi, and Y. Tokura. 2008. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 128 (11):2625–30.

    Article  PubMed  CAS  Google Scholar 

  • Kryczek, I., A. T. Bruce, J. E. Gudjonsson, A. Johnston, A. Aphale, L. Vatan, W. Szeliga, Y. Wang, Y. Liu, T. H. Welling, J. T. Elder, and W. Zou. 2008. Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol 181 (7):4733–41.

    PubMed  CAS  Google Scholar 

  • Kuestner, R. E., D. W. Taft, A. Haran, C. S. Brandt, T. Brender, K. Lum, B. Harder, S. Okada, C. D. Ostrander, J. L. Kreindler, S. J. Aujla, B. Reardon, M. Moore, P. Shea, R. Schreckhise, T. R. Bukowski, S. Presnell, P. Guerra-Lewis, J. Parrish-Novak, J. L. Ellsworth, S. Jaspers, K. E. Lewis, M. Appleby, J. K. Kolls, M. Rixon, J. W. West, Z. Gao, and S. D. Levin. 2007. Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F. J Immunol 179 (8):5462–73.

    PubMed  CAS  Google Scholar 

  • Lande, R., J. Gregorio, V. Facchinetti, B. Chatterjee, Y. H. Wang, B. Homey, W. Cao, B. Su, F. O. Nestle, T. Zal, I. Mellman, J. M. Schroder, Y. J. Liu, and M. Gilliet. 2007. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449 (7162):564–9.

    Article  PubMed  CAS  Google Scholar 

  • Larsen, J. M., C. M. Bonefeld, S. S. Poulsen, C. Geisler, and L. Skov. 2009. IL-23 and T(H)17-mediated inflammation in human allergic contact dermatitis. J Allergy Clin Immunol 123 (2):486–92.

    Article  PubMed  CAS  Google Scholar 

  • Lee, E., W. L. Trepicchio, J. L. Oestreicher, D. Pittman, F. Wang, F. Chamian, M. Dhodapkar, and J. G. Krueger. 2004. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 199 (1):125–30.

    Article  PubMed  CAS  Google Scholar 

  • Leonardi, C. L., A. B. Kimball, K. A. Papp, N. Yeilding, C. Guzzo, Y. Wang, S. Li, L. T. Dooley, and K. B. Gordon. 2008. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Lancet 371 (9625):1665–74.

    Article  PubMed  CAS  Google Scholar 

  • Leung, D. Y., and T. Bieber. 2003. Atopic dermatitis. Lancet 361 (9352):151–60.

    Article  PubMed  Google Scholar 

  • Lew, W., A. M. Bowcock, and J. G. Krueger. 2004. Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and “Type 1” inflammatory gene expression. Trends Immunol 25 (6):295–305.

    Article  PubMed  CAS  Google Scholar 

  • Lew, W., E. Lee, and J. G. Krueger. 2004. Psoriasis genomics: analysis of proinflammatory (type 1) gene expression in large plaque (Western) and small plaque (Asian) psoriasis vulgaris.Br J Dermatol 150 (4):668–76.

    Article  PubMed  CAS  Google Scholar 

  • Li, J., D. Li, and Z. Tan. 2004. The expression of interleukin-17, interferon-gamma, and macrophage inflammatory protein-3 alpha mRNA in patients with psoriasis vulgaris. J Huazhong Univ Sci Technolog Med Sci 24 (3):294–6.

    Article  PubMed  CAS  Google Scholar 

  • Liang, S. C., X. Y. Tan, D. P. Luxenberg, R. Karim, K. Dunussi-Joannopoulos, M. Collins, and L. A. Fouser. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203 (10):2271–9.

    Article  PubMed  CAS  Google Scholar 

  • Liu, Y., C. Helms, W. Liao, L. C. Zaba, S. Duan, J. Gardner, C. Wise, A. Miner, M. J. Malloy, C. R. Pullinger, J. P. Kane, S. Saccone, J. Worthington, I. Bruce, P. Y. Kwok, A. Menter, J. Krueger, A. Barton, N. L. Saccone, and A. M. Bowcock. 2008. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet 4 (3):e1000041.

    Article  PubMed  Google Scholar 

  • Lopez-Candales, A. 2001. Metabolic syndrome X: a comprehensive review of the pathophysiology and recommended therapy. J Med 32 (5–6):283–300.

    PubMed  CAS  Google Scholar 

  • Lowes, M. A., F. Chamian, M. V. Abello, J. Fuentes-Duculan, S. L. Lin, R. Nussbaum, I. Novitskaya, H. Carbonaro, I. Cardinale, T. Kikuchi, P. Gilleaudeau, M. Sullivan-Whalen, K. M. Wittkowski, K. Papp, M. Garovoy, W. Dummer, R. M. Steinman, and J. G. Krueger. 2005. Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc Natl Acad Sci U S A 102 (52):19057–62.

    Article  PubMed  CAS  Google Scholar 

  • Lowes, M. A., T. Kikuchi, J. Fuentes-Duculan, I. Cardinale, L. C. Zaba, A. S. Haider, E. P. Bowman, and J. G. Krueger. 2008. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 128 (5):1207–11.

    Article  PubMed  CAS  Google Scholar 

  • Manel, N., D. Unutmaz, and D. R. Littman. 2008. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 9 (6):641–9.

    Article  PubMed  CAS  Google Scholar 

  • Milner, J. D., J. M. Brenchley, A. Laurence, A. F. Freeman, B. J. Hill, K. M. Elias, Y. Kanno, C. Spalding, H. Z. Elloumi, M. L. Paulson, J. Davis, A. Hsu, A. I. Asher, J. O’Shea, S. M. Holland, W. E. Paul, and D. C. Douek. 2008. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452 (7188):773–6.

    Article  PubMed  CAS  Google Scholar 

  • Morganroth, G. S., L. S. Chan, G. D. Weinstein, J. J. Voorhees, and K. D. Cooper. 1991. Proliferating cells in psoriatic dermis are comprised primarily of T cells, endothelial cells, and factor XIIIa+ perivascular dendritic cells. J Invest Dermatol 96 (3):333–40.

    Article  PubMed  CAS  Google Scholar 

  • Nair, R. P., K. C. Duffin, C. Helms, J. Ding, P. E. Stuart, D. Goldgar, J. E. Gudjonsson, Y. Li, T. Tejasvi, B. J. Feng, A. Ruether, S. Schreiber, M. Weichenthal, D. Gladman, P. Rahman, S. J. Schrodi, S. Prahalad, S. L. Guthery, J. Fischer, W. Liao, P. Y. Kwok, A. Menter, G. M. Lathrop, C. A. Wise, A. B. Begovich, J. J. Voorhees, J. T. Elder, G. G. Krueger, A. M. Bowcock, and G. R. Abecasis. 2009. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 41 (2):199–204.

    Article  PubMed  CAS  Google Scholar 

  • Nair, R. P., A. Ruether, P. E. Stuart, S. Jenisch, T. Tejasvi, R. Hiremagalore, S. Schreiber, D. Kabelitz, H. W. Lim, J. J. Voorhees, E. Christophers, J. T. Elder, and M. Weichenthal. 2008. Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J Invest Dermatol 128 (7):1653–61.

    Article  PubMed  CAS  Google Scholar 

  • Nestle, F. O., C. Conrad, A. Tun-Kyi, B. Homey, M. Gombert, O. Boyman, G. Burg, Y. J. Liu, and M. Gilliet. 2005. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med 202 (1):135–43.

    Article  PubMed  CAS  Google Scholar 

  • Nograles, K. E., L. C. Zaba, A. Shemer, J. Fuentes-Duculan, I. Cardinale, T. Kikuchi, M. Ramon, R. Bergman, J. G. Krueger, and E. Guttman-Yassky. 2009. IL-22-producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 123 (6):1244–52 e2.

    Google Scholar 

  • Nograles, K.E., L. C. Zaba, E. Guttman-Yassky, J. Fuentes-Duculan, M. Suarez-Farinas, I. Cardinale, A. Khatcherian, J. Gonzalez, K.C. Pierson, T.R. White, C. Pensabene, I. Coats, I. Novitskaya, M. A. Lowes, and J.G. Krueger. 2008. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol 159 (5):1092–102.

    PubMed  CAS  Google Scholar 

  • Nurieva, R., X. O. Yang, G. Martinez, Y. Zhang, A. D. Panopoulos, L. Ma, K. Schluns, Q. Tian, S. S. Watowich, A. M. Jetten, and C. Dong. 2007. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448 (7152):480–3.

    Article  PubMed  CAS  Google Scholar 

  • Papp, K. A., R. G. Langley, M. Lebwohl, G. G. Krueger, P. Szapary, N. Yeilding, C. Guzzo, M. C. Hsu, Y. Wang, S. Li, L. T. Dooley, and K. Reich. 2008. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2). Lancet 371 (9625):1675–84.

    Article  PubMed  CAS  Google Scholar 

  • Peric, M., S. Koglin, S. M. Kim, S. Morizane, R. Besch, J. C. Prinz, T. Ruzicka, R. L. Gallo, and J. Schauber. 2008. IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes. J Immunol 181 (12):8504–12.

    PubMed  CAS  Google Scholar 

  • Puel, A., R. Doffinger, A. Natividad, M. Chrabieh, G. Barcenas-Morales, C. Picard, A. Cobat, M. Ouachee-Chardin, A. Toulon, J. Bustamante, S. Al-Muhsen, M. Al-Owain, P. D. Arkwright, C. Costigan,V. McConnell, A. J. Cant, M. Abinum, M. Polak, P. F. Bougneres, D. Kumararatne, L. LMarodi, A. Nahum, C. Roifman, S. Blanche, A. Fischer, C. Bodemer, L. Abel, D. Lilic, and J. L. Casanova. 2010. Autoantibodies against IL-17A, IL-17F and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 207 (2):291–7.

    Google Scholar 

  • Rioux, J. D., R. J. Xavier, K. D. Taylor, M. S. Silverberg, P. Goyette, A. Huett, T. Green, P. Kuballa, M. M. Barmada, L. W. Datta, Y. Y. Shugart, A. M. Griffiths, S. R. Targan, A. F. Ippoliti, E. J. Bernard, L. Mei, D. L. Nicolae, M. Regueiro, L. P. Schumm, A. H. Steinhart, J. I. Rotter, R. H. Duerr, J. H. Cho, M. J. Daly, and S. R. Brant. 2007. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 39 (5):596–604.

    Article  PubMed  CAS  Google Scholar 

  • Sa, S. M., P. A. Valdez, J. Wu, K. Jung, F. Zhong, L. Hall, I. Kasman, J. Winer, Z. Modrusan, D. M. Danilenko, and W. Ouyang. 2007. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J Immunol 178 (4):2229–40.

    PubMed  CAS  Google Scholar 

  • Sabat, R., S. Philipp, C. Hoflich, S. Kreutzer, E. Wallace, K. Asadullah, H. D. Volk, W. Sterry, and K. Wolk. 2007. Immunopathogenesis of psoriasis. Exp Dermatol 16 (10):779–98.

    Article  PubMed  CAS  Google Scholar 

  • Spolski, R., and W. J. Leonard. 2008. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol 26:57–79.

    Article  PubMed  CAS  Google Scholar 

  • Stern, R. S., T. Nijsten, S. R. Feldman, D. J. Margolis, and T. Rolstad. 2004. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 9 (2):136–9.

    Article  PubMed  Google Scholar 

  • Szabo, S. K., C. Hammerberg, Y. Yoshida, Z. Bata-Csorgo, and K. D. Cooper. 1998. Identification and quantitation of interferon-gamma producing T cells in psoriatic lesions: localization to both CD4+ and CD8+ subsets. J Invest Dermatol 111 (6):1072–8.

    Article  PubMed  CAS  Google Scholar 

  • Teraki, Y., A. Miyake, R. Takebayashi, and T. Shiohara. 2004. Homing receptor and chemokine receptor on intraepidermal T cells in psoriasis vulgaris. Clin Exp Dermatol 29 (6):658–63.

    Article  PubMed  CAS  Google Scholar 

  • Teunissen, M. B., C. W. Koomen, R. de Waal Malefyt, E. A. Wierenga, and J. D. Bos. 1998. Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol 111 (4):645–9.

    Article  PubMed  CAS  Google Scholar 

  • Toda, M., D. Y. Leung, S. Molet, M. Boguniewicz, R. Taha, P. Christodoulopoulos, T. Fukuda, J. A. Elias, and Q. A. Hamid. 2003. Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J Allergy Clin Immunol 111 (4):875–81.

    Article  PubMed  CAS  Google Scholar 

  • Toichi, E., G. Torres, T. S. McCormick, T. Chang, M. A. Mascelli, C. L. Kauffman, N. Aria, A. B. Gottlieb, D. E. Everitt, B. Frederick, C. E. Pendley, and K. D. Cooper. 2006. An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis. J Immunol 177 (7):4917–26.

    PubMed  CAS  Google Scholar 

  • Trifari, S., C. D. Kaplan, E. H. Tran, N. K. Crellin, and H. Spits. 2009. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 10 (8):864–71.

    Article  PubMed  CAS  Google Scholar 

  • Volpe, E., M. Touzot, N. Servant, M. A. Marloie-Provost, P. Hupe, E. Barillot, and V. Soumelis. 2009. Multiparametric analysis of cytokine-driven human Th17 differentiation reveals a differential regulation of IL-17 and IL-22 production. Blood 114 (17):3610–4.

    Article  PubMed  CAS  Google Scholar 

  • Watson, W., H. M. Cann, E. M. Farber, and M. L. Nall. 1972. The genetics of psoriasis. Arch Dermatol 105 (2):197–207.

    Article  PubMed  CAS  Google Scholar 

  • Wei, L., A. Laurence, K. M. Elias, and J. J. O’Shea. 2007. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J Biol Chem 282 (48):34605–10.

    Article  PubMed  CAS  Google Scholar 

  • Williams, R. C., A. W. McKenzie, J. H. Roger, and V. C. Joysey. 1976. HL-A antigens in patients with guttate psoriasis. Br J Dermatol 95 (2):163–7.

    Article  PubMed  CAS  Google Scholar 

  • Wright, J. F., Y. Guo, A. Quazi, D. P. Luxenberg, F. Bennett, J. F. Ross, Y. Qiu, M. J. Whitters, K. N. Tomkinson, K. Dunussi-Joannopoulos, B. M. Carreno, M. Collins, and N. M. Wolfman. 2007. Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells. J Biol Chem 282 (18):13447–55.

    Article  PubMed  CAS  Google Scholar 

  • Zaba, L. C., I. Cardinale, P. Gilleaudeau, M. Sullivan-Whalen, M. Suarez Farinas, J. Fuentes-Duculan, I. Novitskaya, A. Khatcherian, M. J. Bluth, M. A. Lowes, and J. G. Krueger. 2007. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med 204 (13):3183–94.

    Article  PubMed  CAS  Google Scholar 

  • Zaba, L. C., M. Suarez-Farinas, J. Fuentes-Duculan, K. E. Nograles, E. Guttman-Yassky, I. Cardinale, M. A. Lowes, and J. G. Krueger. 2009a. Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes. J Allergy Clin Immunol 124 (5):1022–10 e1-395.

    Google Scholar 

  • Zaba, L.C., J. Fuentes-Duculan, N.J. Eungdamrong, M.V. Abello, I. Novitskaya, K.C. Pierson, J. Gonzalez, J.G. Krueger, and M.A. Lowes. 2009b. Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 Cell-Polarizing Myeloid Dendritic Cells. J Invest Dermatol 129:79–88.

    Article  PubMed  CAS  Google Scholar 

  • Zhao, Y., A. Balato, R. Fishelevich, A. Chapoval, D. L. Mann, and A. A. Gaspari. 2009. Th17/Tc17 infiltration and associated cytokine gene expression in elicitation phase of allergic contact dermatitis. Br J Dermatol 161 (6):1301–6.

    Article  PubMed  CAS  Google Scholar 

  • Zheng, Y., D. M. Danilenko, P. Valdez, I. Kasman, J. Eastham-Anderson, J. Wu, and W. Ouyang. 2007. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445 (7128):648–51.

    Article  PubMed  CAS  Google Scholar 

  • Zhou, L., Ivanov, II, R. Spolski, R. Min, K. Shenderov, T. Egawa, D. E. Levy, W. J. Leonard, and D. R. Littman. 2007. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8 (9):967–74.

    Google Scholar 

Download references

Acknowledgement

This publication was made possible by grant number 5UL1RR024143 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. JGK has received research grants from Amgen, Centocor, Wyeth and Eli Lilly for the study of therapeutic agents related to the IL-23/TH17 pathway.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to James G. Krueger .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Nograles, K.E., Davidovici, B., Krueger, J.G. (2011). IL-23/TH17 Pathway in Psoriasis and Inflammatory Skin Diseases. In: Jiang, S. (eds) TH17 Cells in Health and Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9371-7_25

Download citation

Publish with us

Policies and ethics